Text Size

History, presence, and future of mitomycin C in glaucoma filtration surgery

Wolters J.E.J., van Mechelen R.J.S., Al Majidi R., Pinchuk L., Webers C.A.B., Beckers H.J.M., Gorgels T.G.M.F.


  • 2021
  • Current opinion in ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Post-Approval studies/RWE

  • Affiliations

    Wolters, J.E.J., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; van Mechelen, R.J.S., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Al Majidi, R., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Pinchuk, L., InnFocus, Inc., Santen Company, Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Webers, C.A.B., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Beckers, H.J.M., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Gorgels, T.G.M.F., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022